CONCLUSION ET
RECOMMANDATIONS
CONCLUSION ET
RECOMMANDATIONS
Au terme de notre étude, nous concluons que :
F Les enfants infectés par le virus VIH
présentent un retard statural et pondéral et une
émaciation durant les douze mois d'étude.
F Ils présentent tous un faible WAZ, HAZ, WHZ
malgré la mise sous traitement anti rétroviral qui ne semble pas
améliorer la croissance staturale, mais augmente le gain
pondéral.
D'où les recommandations suivantes :
F Aux personnels soignants : Renforcer
le dépistage volontaire du VIH chez les nouveau-nés et le suivi
de la croissance staturo pondérale des enfants nés de
mères séropositives.
F A la Faculté de Médecine et des
Sciences Biomédicales et à la Communauté
Scientifique : Encourager toute étude pouvant accroitre la
taille de l'échantillon d'un tel travail.
BIBLIOGRAPHIE
BIBLIOGRAPHIE
1. ONUSIDA/OMS.
Le point sur l'épidémie de SIDA. Rapport
spécial sur la prévention du VIH; 2007; Déc.
2. Ministère de la Santé Publique du Cameroun.
Prévention de la Transmission du VIH de la Mère à
l'Enfant : Guide de Poche; 2006 Août.
3. Ministère de la Santé Publique du Cameroun.
Guide de prise en charge des enfants exposés et infectés par le
VIH/SIDA; 2006 Déc.
4. Moye J, Kenneth CR, Leslie AK, Amy RS, Clemente D, Ellen
RC. For the Women and Infants Transmission Study Group.
Natural history of somatic growth in infants born to women
infected by human immunodeficiency virus.
J Pediatr 1996;128:58-69.
5. Arpadi SM.
Growth failure in children with HIV infection.
JAIDS 2000;25:S37-S42.
6. McKinney RE, Robertson JWR and the Duke Pediatric AIDS
Clinical Trials Unit.
Effect of human immunodeficiency virus infection on the growth
of young children.
J Pediatr 1993; 123:579-82.
7. Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P, St Louis ME.
Growth of children according to maternal and child HIV,
immunological and disease characteristics: a prospective cohort study in
Kinshasa, Democratic Republic of Congo.
Int J Epidermiol 1999;28:532-40.
8. Beau JP, Imboua-Coulibaly L.
Caractéristiques anthropométriques d'enfants
malnutris infectés par le VIH en Côte d'Ivoire.
Cahiers Santé 1997 ; 7:236-8.
9. Brun-Vézinet F, Damond F, Descamps D, Simon F.
Virus de l'immunodéficience humaine. EMC 2000.
10. Manuel sur le SIDA pédiatrique en Afrique.
Edité par le Réseau Africain pour
les soins aux enfants affectés par le SIDA,
Edition Révisée, 2006 Jul.
11. Blanche S.
Infection de l'enfant par le virus de
l'immunodéficience humaine.
EMC 4-310-A-40.
12. Mawamba YN.
Les présentations cliniques du SIDA pédiatrique
à Yaoundé. Thèse de Doctorat en Médecine,
Faculté de Médecine et des Sciences biomédicales de
l'Université de Yaoundé I. 2003.
13. Zeh OF.
VIH et malnutrition : critères cliniques du SIDA
pédiatrique et malnutrition protéino énergétique
sévère à l'hôpital Central de Yaoundé.
Thèse de Doctorat en Médecine, Faculté de Médecine
et des Sciences biomédicales de l'Université de Yaoundé I.
1998.
14. WHO. Antiretroviral therapy of HIV infection in infants
and children in resource-limited settings: towards universal access. 2006.
15. Brauner R.
Conduite pratique devant une anomalie de la croissance. EMC
4-005-A-10. 2003.
16. Africa nutrition chartbooks. Appendix 2. WHO/CDC/NCHS
International Reference Population, Normal Distribution 45, Page 5.
17. Fanta project. Guide de mesure des indicateurs
anthropométriques.
Cogill B. 2003 Mar.
18. Ryder RW, Nsa W, Hassig SE.
Prenatal transmission of the human immunodeficiency virus type
1 to infants of seropositive women in Zaire.
N Engl J Med 1989;320:1637-42.
19. Miller TL, Evans SJ, Orav EJ, Moris V, Mc Intosh K, Winter
H.
Growth and body composition in children infected with the
human immunodeficiency virus-1.
Am J Clin Nutr 1993;57:588-92.
20. Lepage P, Msellati P, Hitimana D-G, Bazubagira A, Van
Goethem C, Simonon A et al.
Growth of human immunodeficiency type 1-infected and
uninfected children: a prospective cohort study in Kigali, Rwanda, 1998 to
1993.
Pediatr Infect Dis J 1996 Jun; 15(6):479-485.
21. Arpadi SM.
Consultation on Nutrition and HIV/AIDS in Africa: Evidence,
lessons and recommendations for action, Durban, South Africa, 2005 April 10-13,
Department of Nutrition for Health and Development, World Health
Organization.
22. Hirschfeld S.
Dysregulation of growth and development in HIV-Infected.
J Nutr 1996;126: 2641S-50S.
23. Macallan DC, Noble C, Baldwin C, Jebb SA, Pretice AM,
Coward WA.
Energy expenditure and wasting in human immunodeficiency virus
infection.
N Engl J Med 1995;333:83-8.
24. Johann-Liang R, O'Neill L, Cervia J, Haller I, Giunta Y,
Licholai T, et al.
Energy balance, viral burden, insulin-like growth factor-1,
interleukin-6 and growth impairment in children infected with human
immunodeficiency virus. AIDS 2000, 14:683-90.
25. Winter H.
Gastrointestinal tract in HIV-infected children function and
malnutrition.
J Nut 1996; 126: 2620S-2S.
26. Berhane R, Bagenda D, Marum L, Aceng E, Ndugwa C, Ronald
J, et al.
Growth failure as a prognostic indicator of mortality in
pediatric HIV infection. Pediatrics 1997; 100(1): 1- 4.
27. CDC. 1994 revised classification system for human
immunodeficiency virus infection in children less than 13 years of age.
Morb Mortal Wkly Rep 1994; 43:1-10.
28. Lepage P, Hitimana DG.
Natural history and clinical presentation of HIV-1 infection
in children.
AIDS 1991; 5 (suppl.1) : 117-25.
29. Kurawige JB, Gatsinzi T, Kleinfeldt V.
HIV-1 infection among malnourished children in Butare, Rwanda.
J Trop Pediatr 1993; 39: 93-6.
30. Campanozzi A, Goulet O, Dabbas M.
Body composition of human immunodeficiency virus infected
children.
First International Conference on Nutrition and HIV
infection/Cannes/1995. Abstract. P007.
31. Fleiss JL, Levin B and Paik MC. (2003). Statistical
Methods for Rates and Proportions (3rd ed.). New York: John Wiley & Sons.
32. Sample Size for Cross-Sectional, Cohort, & Randomized
Clinical Trial Studies.
33. MINSANTE Cameroun. Carte de la mère, 2006.
Recommandations pour l'alimentation (pour l'enfant malade et en bonne
santé).
34. Webb AL, Manji K, Fawzi WW, Villarmor E.
Time-independent maternal and infant factors and time
-dependent infant morbidities including HIV infection, contribute to infant
growth faltering during zhe first two years of life.
J Trop Pediatr 2008 Aug; 55(2): 83-90.
35. Hamill PVV, Drizd TA, Johnson CL, Reed BB, Roche AF, Moore
VM.
Physical Growth: National Center for Health Statistics
percentiles.
Am J Clin Nutr 1979; 32: 607-29.
36. World Health Organization Working Group. Use and
interpretation of anthropometric indicators of nutritional status.
Bull World Health Organ 1986;64:929-41.
37. Kaufmann FR, Gomperts ED.
Growth failure in boys with haemophilia and HIV infection.
Am J Pediatr Hematol Oncol 1989; 11: 292-4.
38. Laue L, Pizzo PA, Butler K, Culter GB Jr.
Growth and neuro endocrine dysfunction in children with
acquired immunodeficiency syndrome.
J Pediatr 1990; 117: 541-5.
39. Lepage P, Van de Perre P, Van Vliet G.
Clinical and endocrinological manifestations in perinatally
HIV-1 infected children aged five years or more.
AJDC 1991; 145: 1248-51.
40. Geffner ME, Yeh DY, Landaw EM.
In vitro insulin-like growth factor-I, growth hormone, and
insulin resistance occurs in symptomatic human immunodeficiency
virus-I-infected children. Pediatr Res 1993;34:66-72.
41. Oberfield SE, Kairam R, Bakshi S.
Steroids response to adrenocorticotropinstimulation in
children with human immunodeficiency virus infection.
J Clin Endocrinol Metab 1990;70:578-81.
42. Blum WF.
Insulin-like growth factors (IGFs) and IGF binding proteins in
chronic renal failure: Evidence for reuced secretion of IGFs.
Acta Paediatr 379:24-31, 1991 (suppl).
43. Grunfeld C, Mulligan K, Hellertsein M.
Growth hormone therapy promotes positive nitrogen balance and
weight gain in AIDS. Program and Abstracts of the English of International
Conference on AIDS, Amsterdam, 1992, pB230 (abstr PoB 3835).
44. Yip R, Parvanta I, Scanlon K, Borland EW, Russell CM,
Trowbridge FL. Pediatric Nutrition Surveillance System-United States,
1980-1991. MMWR 1992; 41: (SS-7): 1-24.
45. Abrams DI.
Potential Interventions for HIV/AIDS Wasting: An Overview.
JAIDS 2000 Oct; 25 (1): S74-S80.
46. Jospe N, Powell KR.
Growth hormone deficiency in a 8-year old girl with human
immunodeficiency virus infection.
Pediatrics 1990; 86: 309-12.
47. Grunfeld C, Pang M, Simuzy L, Shinegaga Jk, Jensen P,
Feingold KR. Resting energy expenditure, caloric intake and short-term weight
charge in human immunedeficiency virus infection and acquired immunodeficiency
syndrome.
Am J Clin Nutr 1992; 55: 455-60.
48. Shet A, Mehta S, Rajagopalan N, Dinakar C, Ramesh E,
Samuel NM et al. Anemia and growth failure among HIV-infected children in
India: A retrospective analysis.
BMC Pediatrics 2009, 9:37 (1-9).
49. Saaverdra Jm, Henderson RA, Perman JA.
Longitudinal assement of growth in children born to mothers
with human immunodeficiency virus infection.
Arch Pediatr Adolesc Med 1995; 149: 497-502.
50. Beau JP, Imboua-Coulibaly.
Body Mass Index : A prognosis Factors Among HIV
Seropositive Malnourished Children.
J Trop Pediatr 1997 Oct; 43:301-03.
51. Roche AF, Siervogel RM, Chumlea WC, Webb P.
Grading body fatness from limited anthropometric data.
Am J Clin Nutr 1981; 34:2831-8.
52. Siervogel RM, Roche AF, Guo S, Mukheryee d, Chumlea WC.
Patterns of change in weight/stature2 from 2 to 18 years:
findings from long term serial data for children in the fels longitudinal
growth study.
Int J Obesity 1991; 15: 479-85.
53. Pfeiffer A, Mentzer D, Stroh S.
Body composition and food records in vertically HIV infected
children. XI International Conference on AIDS/Vancouver/1996.
Abstract Tu. B. 2250
54. Castetbon K, Landner J, Leroy V.
Low birth weight in infants born to African HIV-infected
woman : relation ship with maternal body weight during pregnancy.
J Trop Pediatr 1999; 45:152-7.
55. Lepage P, Dabis F, Hitimana DG.
Perinatal transmission of HIV-1: Lack of impact of maternal
HIV infection on characteristics of live births and neonatal mortality in
Kigali, Rwanda.
AIDS 1991;5:295-300.
56. Mc Kinney JrRE, Maha MA, Connor EM.
A multicenter trial of oral Zidovudine in children with
advance human immunodeficiency virus disease.
N Engl J Med 1991; 324:1018-25.
57. Mc Kinney RE, ACTGProtocol 043 Study Group: Markers
Pronostic for Survival in Zidovudine treated, HIV infected children.
Pediatr Res 1994; 35:187A, (abstr 1105)
58. Mc Kinney RE, Pizzo PA, Scott GB.
Safety and tolerance of intermittent intravenous and oral
Zidovudine therapy in human immunodeficiency virus infected pediatrics
patients.
J Pediatr 1990; 116:640-647.
59. Butler KM, Husson RN, Balis FM.
Dideoxynosine in children with symptomatic human
immunodeficiency virus infection.
N Engl J Med 1991; 324:1437-44.
60. Lettre - Circulaire du 06 Août 2008. Le Ministre de
la Santé Publique. Mise en place du traitement antiretroviral
précoce des enfants infectés au VIH au Cameroun.
| 
